INDIAN MARKET Due to poor sanitation conditions, infectious (acute) diseases are predominant in India. However, the incidence of chronic ailments, characterised by prolonged exposure, has been increasing with the emergence of lifestyle diseases in India, due to changing work pattern of the working population, higher stress levels, and unhealthy eating habits. Key issues answered through this analysis: What are acute and chronic ailments? What is the proportion of drugs for each segment in
Words: 12248 - Pages: 49
three most profitable industries in the United States for the past two decades. Studies show that marketing strategies used by pharmaceutical representatives such as education, samples, office support, and patient resources can increase brand recognition and influence prescribing. This leads to patients being influenced to spend more money on the brand name drugs, rather than the cheaper generic versions that work exactly the same. References Insert References Here. Place the cursor at the beginning
Words: 276 - Pages: 2
pharmaceutical company in Bangladesh .The Company was founded in 1958 by Samson H. Chowdhury along with three of his friends as a private firm. It was converted into a public limited company in 1991. It is engaged in the manufacturing of branded generic pharmaceutical products and also other ethical drugs and medicines. The company formulation facilities include Pabna Unit, Dhaka Unit, Pesticide Unit, Cephalosporin Unit and Animal Health Unit. Square Pharmaceuticals Limited has extended its range
Words: 4423 - Pages: 18
1. Overview of Pharmaceutical Industry The pharmaceutical industry faced significant growth during the last decade with companies such as Merck, benefitting from a lack of competition, no comparable substitute products or generics and consumers who were at the mercy of the pharmaceutical companies. However, in the
Words: 2468 - Pages: 10
Generoso Pharmaceuticals and Chemicals, Inc. David Generoso could feel his “five-year itch” once more. He already had behind him 15 years of experience in the pharmaceutical industry and was managing an interesting portfolio of business revolving around pharmaceutical and chemical products. Still, he felt he had not exhausted the opportunities, which the industry had to offer. David considered himself handicapped with a short patience. He wished he had pursued a more stable career path
Words: 4065 - Pages: 17
Introduction of Pfizer Pfizer is an American multinational pharmaceutical corporation that headquartered in New York City [Pfizer. Retrieved on April 3, 2010] and with its research headquarters in Groton, Connecticut and United States. It is one of the world's largest pharmaceutical companies by revenues.[Bloomberg Businessweek. 27 March 2012. Retrieved 8 July 2012] Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines that includes immunology, oncology,
Words: 2504 - Pages: 11
The review of a business model Bachelor assignment THE REVIEW OF A BUSINESS MODEL Research on changing the business model for a Dutch tour operator Leon van der Heijden ‐ June 2010 University of Twente Faculty: School of Management and Governance Education: Industrial Engineering & Management Drienerlolaan 5 7522 NB Enschede www.mb.utwente.nl Supervisor: Dr. K. (Kasia) Zalewska‐Kurek Co‐reader: Dr. J. (Joris) M
Words: 27366 - Pages: 110
GCC Pharmaceutical Industry March 31, 2013 Alpen Capital was awarded the “Best Research House” at the Banker Middle East Industry Awards 2011 GCC Pharmaceutical Sector | March 31, 2013 Page | 2 Table of Contents 1. 1.1. 1.2. 1.3. 1.4. EXECUTIVE SUMMARY............................................................................ 6 Scope of the Report .................................................................................. 6 Key Growth Drivers ........................
Words: 27542 - Pages: 111
Background I C. The Rational for the Acquisition I D. Standalone, Synergy and Premium Valuations II E. Integration Plan II Part 1 - The Rational of the Acquisition 1 1. Pfizer's Strategy 1 1.1. Pfizer Growth Strategy 2 2. Pfizer's Road Map 4 2.1. Pfizer's Acquisitions Rational 4 3. The strategy behind the acquisition 5 3.1. Acquisition Motives 5 3.2. M&A vs. Alliance 5 4. Target Identification 7 4.1. Protalix - an R&D Acquisition 9 5. Synergy Analysis 10 6. Standalone
Words: 10031 - Pages: 41
“Beximco Pharma aspires to become a nationally admired and globally reputed generic pharmaceutical company, committed to enhancing human health and life.” Annual Report 2010 Beximco Group Mission Each of our activities must benefit and add value to the common wealth of our society.We firmly believe that, in the final analysis we are accountable to each of the constituents with whom we interact, namely: our employees, our customers, our business associates, our fellow citizens and our
Words: 11101 - Pages: 45
